Investigation of the presence of cervical human papillomavirus and the distribution of preinvasive lesions in patients using immunomodulators-Inosine Pranobex

Abstract Background Human papillomavirus treatment is known to benefit from humoral and cellular immunity. It has been demonstrated that the immunomodulatory drug Inosine Pranobex (IP) increases T-cell proliferation, the number and function of natural killer cells, and the levels of T helper 1-type...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Belma Gözde Özdemir, Gunay Safarova, Osman Yıldırım, Mercan Aslan, Fazıl Avcı, Ahmet Bilgi, Çetin Çelik
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-02-01
Edice:	Infectious Agents and Cancer
Témata:	Immunomodulator Cervical precancerous Malignancy HPV Inosine Pranobex
On-line přístup:	https://doi.org/10.1186/s13027-026-00742-x
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!